November Marks National Bladder Health Month

November 01, 2017
MS Focus: the Multiple Sclerosis Foundation kicks off the Bladder Health Month campaign along with the Urology Care Foundation, American Urological Association and numerous other organizations from the Bladder Health Alliance.
 
This monthlong awareness campaign was developed to increase the focus on “Getting the Facts, Getting Diagnosed and Taking Control” of bladder health. Bladder health support materials are now available at: www.AUAnet.org/BHM17 and www.UrologyHealth.org/BHM17.
 
MS can affect the bladder in several ways, adding even more symptoms to this complicated, chronic illness. Each day, millions of Americans struggle with the effects of bladder conditions and disease such as urinary incontinence, overactive and underactive bladder, interstitial cystitis, urinary tract infections, nocturia, bedwetting, bladder cancer and neurogenic bladder. These conditions can have a significant effect on an individual’s health and quality of life, and result in substantial health costs (estimated to be more than $70 billion per year).
 
As a member of the Bladder Health Alliance, MS Focus hopes to remove the stigma surrounding bladder health. “Many people are too embarrassed to talk about their bladder health symptoms so they go unreported or untreated – they don’t realize these symptoms and conditions can be controlled or corrected through simple lifestyle changes, behavior modifications or diet and exercise,” the President of the Urology Care Foundation said.
 
To help raise awareness and remove the stigma surrounding bladder health, arm yourself with knowledge by visiting The Urology Care Foundation’s web page at www.urologyhealth.org/media-center/bladder-health-month-2017.
 
For more information on a how multiple sclerosis affects bladder health, please contact MS Focus: the Multiple Sclerosis Foundation at 888-673-6287 or 954-776-6805.

MS Focus Lending Library


Books, DVDs, and CDs are available for loan, by mail across the United States.
Learn more

Study uncovers potential risks of common MS treatment


Study finds an increased risk of events such as stroke, migraine, and depression, and abnormalities in the blood with taking beta interferon for MS.
Learn more